UK markets close in 6 hours 21 minutes

  • FTSE 100

    6,684.71
    -10.36 (-0.15%)
     

  • FTSE 250

    20,562.79
    -34.12 (-0.17%)
     

  • AIM

    1,205.15
    +9.84 (+0.82%)
     

  • GBP/EUR

    1.1254
    +0.0017 (+0.15%)
     

  • GBP/USD

    1.3674
    -0.0010 (-0.07%)
     

  • BTC-GBP

    24,169.32
    -270.35 (-1.11%)
     

  • CMC Crypto 200

    669.15
    -7.75 (-1.14%)
     

  • S&P 500

    3,841.47
    -11.60 (-0.30%)
     

  • DOW

    30,996.98
    -179.02 (-0.57%)
     

  • CRUDE OIL

    52.66
    +0.39 (+0.75%)
     

  • GOLD FUTURES

    1,855.20
    -1.00 (-0.05%)
     

  • NIKKEI 225

    28,822.29
    +190.84 (+0.67%)
     

  • HANG SENG

    30,159.01
    +711.16 (+2.41%)
     

  • DAX

    13,863.31
    -10.66 (-0.08%)
     

  • CAC 40

    5,539.64
    -19.93 (-0.36%)
     
DAVOS 2021:

Increase in world's 10 richest men's wealth during pandemic could pay for globe's COVID-19 vaccine

The world’s ten richest men have seen their combined wealth increase by $540bn

SoftBank-backed SVF Investment raises $525 million in IPO

·1-min read

(Reuters) - Blank-check company SVF Investment Corp, backed by SoftBank Group Corp, said on Thursday it sold shares in its initial public offering at $10 per unit to raise $525 million.

SVF Investment is sponsored by SoftBank Investment Advisers, which runs the $100 billion fund and said it could invest in a new or existing portfolio company.

SVF Investment was formed for the purpose of an effective merger or conducting similar business. SoftBank Group had cited sectors such as artificial intelligence and robotics as possibilities, in line with its broader investing thesis.

The launch of the special purpose acquisition (SPAC) marks an appeal to investors after earlier efforts to raise capital for a second Vision Fund floundered following missteps.

SPACs have emerged as a popular IPO alternative for companies, providing a path to going public with less regulatory scrutiny and more certainty over the valuation that will be attained and funds that will be raised.

The units will be listed on the Nasdaq under the ticker "SVFAU" beginning on Jan. 8, the company said. (https://refini.tv/3oksXqp)

Citigroup Global Markets Inc, Deutsche Bank Securities Inc, and Cantor Fitzgerald & Co are acting as book-running managers in the offering.

(Reporting by Trisha Roy in Bengaluru, Editing by Sherry Jacob-Phillips)

Latest stories

  • Adele reflects on '21' as album reaches 10th anniversary

    The singer said she 'remembered little' of what it was like at the time and how she felt.

  • Saudi Arabia Replaces Central Bank Head, Lays Out Fund Goals

    (Bloomberg) -- Saudi Arabia replaced its central bank governor and said it would more than double the size of its sovereign wealth fund by 2025 as Crown Prince Mohammed bin Salman sets the stage for a flagship investment conference this week.Ahmed Alkholifey was removed from his position heading the monetary authority. He is being replaced by Fahad Al-Mubarak, who was central bank governor from 2011 to 2016. The reason for the change wasn’t given.The central bank and the $400 billion Public Investment Fund are set to play an increasingly important role in powering the domestic recovery as the government looks to boost an economy hit by the twin shocks of the coronavirus pandemic and low oil prices. The central bank’s mandate was recently expanded to include supporting economic growth, while the crown prince has said the wealth fund would invest $40 billion a year domestically.The moves highlight the growing role for both institutions in driving the kingdom’s future growth at a time when the budget is unable to do this anymore, said Mohamed Abu Basha, head of macroeconomic research at EFG Hermes Holding.“PIF is set to be by far the key growth engine of the kingdom in the next few years,” he said. “An active central bank, that now has within its mandate to support economic growth, can complement these efforts by focusing on financing initiatives. The success story in the housing sector is a case in point.”Al-Mubarak, the new governor, had most recently been a minister of state and served as the kingdom’s sherpa during its presidency last year of meetings of the Group of 20 industrialized economies. He was also previously chairman of Morgan Stanley’s Saudi Arabia unit.What Bloomberg Economics Says...“As the governor of a central bank with a pegged currency, the role isn’t the classic one of setting interest rates. The importance of the post is in being the custodian of the country’s foreign exchange reserves.”\-- Ziad Daoud, chief emerging-markets economistSaudi Arabia pegs its currency to the dollar and tends to move in lockstep with the U.S. Federal Reserve. The change in leadership is unlikely to affect the central bank’s policy, with most levers of decision-making in the kingdom controlled by Prince Mohammed.Saudi Arabia’s central bank has already been one of the key vehicles for providing stimulus to the economy as Covid-19 and low oil prices hobble the private sector. The monetary authority has extended over 100 billion riyals ($27 billion) to local banks in liquidity injections and to cover the costs of loan deferrals for small businesses hit by the pandemic.Lead RoleThe central bank also controls the kingdom’s reserves, which are among the largest in the world at 1.7 trillion riyals. But its historic role as manager of the country’s savings is being eclipsed by the PIF, which is chaired by the crown prince.The PIF received a $40 billion transfer from the central bank in March for new investments as it looked to capitalize on a slump in global markets caused by the onset of the coronavirus. It later disclosed it had spent about $10 billion buying stakes in blue-chip Western firms, which it sold a few months later as markets recovered.The wealth fund will host its annual investor conference within days, with the global pandemic making most of the proceedings virtual. Since its launch in 2017, the Future Investment Initiative has played host to hundreds of corporate titans including JPMorgan Chase and Co.’s Jamie Dimon and Softbank’s Masayoshi Son. The event has helped establish the fund’s reputation as a major source of international investment.In a separate announcement on Sunday, Prince Mohammed said that the sovereign wealth fund aims to manage 4 trillion riyals by 2025, making it one of the biggest government-controlled investors in the world.If the PIF reaches that goal, it would eclipse the current size of China Investment Corp. and be similar to Norway’s giant sovereign fund.(Updates with new analyst comment in paragraphs 4-5)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Here are 3 ways to aim to make a million from UK shares

    It is possible to make a million from UK shares but do not underestimate the challenge, and don't waste time if you want to build this mighty sum. The post Here are 3 ways to aim to make a million from UK shares appeared first on The Motley Fool UK.

  • Asia Pacific $1.8 Billion Nuclear Decommissioning Service Market Forecast to 2027 - ResearchAndMarkets.com

    The "Asia Pacific Nuclear Decommissioning Service Market Forecast to 2027- COVID-19 Impact and Analysis by Reactor Type; Strategy; Application; Capacity and Country" report has been added to ResearchAndMarkets.com's offering.

  • ByteDance Foe Seeks $5.4 Billion in Biggest Tech IPO Since Uber

    (Bloomberg) -- Kuaishou Technology, the operator of China’s most popular video service after ByteDance Ltd.’s Douyin, is seeking to raise as much as $5.4 billion in the world’s biggest internet initial public offering since Uber Technologies Inc.The short video startup, backed by Tencent Holdings Ltd., is selling 365 million shares at HK$105 to HK$115 each, according to terms of the deal obtained by Bloomberg News. The company will start taking investor orders from Monday through Jan. 29 and is slated to list on Feb. 5 in Hong Kong.Kuaishou is attempting the world’s biggest internet IPO since Uber’s $8.1 billion U.S. share sale in May 2019, according to data compiled by Bloomberg. The Chinese startup’s IPO will also give another boost to Hong Kong’s already-hot capital market and could become Asia’s largest since Budweiser Brewing Co. APAC Ltd.’s $5.8 billion float almost two years ago.Kuaishou, which means “fast hand,” is one of China’s biggest internet success stories of the past decade, part of a generation of startups that thrived with backing from Tencent. Along with TikTok parent ByteDance, the outfit co-created by Su Hua in 2013 pioneered the live streaming and bite-sized video format that’s since been adopted around the world by the likes of Facebook Inc. Kuaishou’s imminent debut could test investor appetite for its far larger rival, which was last valued at $180 billion.Tencent and IPO advisor China Renaissance Holdings Ltd. surged in Hong Kong, suggesting enthusiasm for its upcoming debut. On Monday, Kuaishou executives revealed monthly active users on its main app had reached 481.4 million while average daily time spent had crossed the 100-minute mark in 2021. Co-founder Su emphasized his company was pursuing future growth by applying its popular video formats to a range of online services like shopping.“We are exploring live-streaming in local life services and knowledge sharing,” the 38-year-old former Google engineer told investors on a conference call. “We’ll also try to use short videos and live-streaming, both based on the fan-host relationship, to transform one industry after another. That’s a driving force for our future growth.”Read more: ByteDance Seeks Funds at $180 Billion Value Before IPO of AssetsThe offering of Kuaishou has attracted 10 cornerstone investors, who agreed to subscribe for $2.45 billion of stock, based on the mid-point of the marketed range. The lineup includes The Capital Group, Temasek Holdings Pte, GIC Pte, BlackRock Inc. and Abu Dhabi Investment Authority, the terms show, confirming an earlier Bloomberg News report. The cornerstone investors have agreed to hold stock for six months in exchange for early, guaranteed allocation.The valuation of Kuaishou could more than double after its Hong Kong IPO. A top-end pricing will value the Chinese firm at $60.9 billion, up from the $28.6 billion it achieved in a funding round last year, according to Pitchbook. Even at the low end of the range, Kuaishou will still be valued at $55.6 billion.ByteDance has long been a rumored IPO candidate but was bogged down last year in fighting a U.S. ban on TikTok after the video service was labeled a national security threat. The social media giant was in discussions to raise $2 billion before listing some of its businesses in Hong Kong, Bloomberg News reported in November.Kuaishou had about 262 million average daily active users as of September, according to its prospectus. That’s still less than half the 600 million on Douyin, the Chinese version of TikTok. That said, Kuaishou’s revenues climbed 49% to 40.7 billion yuan ($6.3 billion) in the first nine months of last year, after it ratcheted up monetization efforts through advertising and e-commerce. While it offers free access to its main platform, the startup takes a cut of the tips users give to their favorite live-streamers who perform viral challenges, lip-synch to the latest pop songs and play video games.Tencent has about a 21.6% stake in Kuaishou, and other backers include venture capital firms DCM, DST Global and Sequoia Capital China, the prospectus shows. Shares in Tencent jumped 11% and closed at an all-time high on Monday in Hong Kong.Morgan Stanley, Bank of America Corp. and China Renaissance are joint sponsors of the deal.(Updates Tencent’s shares to closing level in 11th paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • EU seeks answers from AstraZeneca on cut to vaccine supplies in Monday meeting

    The European Union will meet AstraZeneca executives on Monday to seek further clarification on why they unexpectedly announced a large cut in supplies of COVID-19 vaccine to the bloc for the first quarter of the year, EU officials said. AstraZeneca, which developed its shot with Oxford University, told the EU on Friday that it could not meet the agreed supply targets running up to the end of March, with an EU official telling Reuters that meant a 60% cut to 31 million doses. The Anglo-Swedish drugmaker has received an up-front payment of 336 million euros ($409 million) from the EU, a second EU official told Reuters when the 27-nation bloc sealed a supply deal with AstraZeneca in August for at least 300 million doses - the first signed by the EU to secure COVID-19 shots..

  • Nike urges court to throw out EU probe into Dutch tax deal

    U.S. sportswear maker Nike on Monday urged Europe's second-highest court to annul an EU investigation into its Dutch tax rulings, saying the bloc's competition enforcers had failed to show these amounted to illegal state aid. The European Commission launched an investigation into Nike's Dutch tax status in January 2019, part of a crackdown on multinationals' sweetheart tax deals with EU countries giving them an unfair advantage. At issue are five tax rulings issued by Dutch authorities from 2006 to 2015, two of which are still in force, which endorsed a method to calculate royalty payments to Nike's Dutch entities - Nike European Operations Netherlands and Converse Netherlands - for the use of intellectual property.

  • Primary Sclerosing Cholangitis Epidemiology in 7MM, 2017-2030: United States, Germany, Spain, Italy, France, UK and Japan

    Dublin, Jan. 25, 2021 (GLOBE NEWSWIRE) -- The "Primary Sclerosing Cholangitis - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. Primary Sclerosing Cholangitis - Epidemiology Forecast to 2030 delivers an in-depth understanding of the disease, historical, and forecasted Primary Sclerosing Cholangitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.Geographies Covered The United StatesEU5 (Germany, France, Italy, Spain, and the United Kingdom)Japan Study Period: 2017-2030Epidemiology PerspectiveThis section encompassing Primary Sclerosing Cholangitis epidemiology provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Primary Sclerosing Cholangitis epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. This segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.Detailed Epidemiology SegmentationThe Primary Sclerosing Cholangitis epidemiology covered in the report provides historical as well as forecasted Primary Sclerosing Cholangitis epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.Scope of the Report The Primary Sclerosing Cholangitis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patternsThe Primary Sclerosing Cholangitis report and model provide an overview of the global trends of Primary Sclerosing Cholangitis in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).The report provides insight into the historical and forecasted patient pool of Primary Sclerosing Cholangitis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.The report helps recognize the growth opportunities in the 7MM concerning the patient population.The report assesses the disease risk and burden and highlights the unmet needs of Primary Sclerosing Cholangitis.The report provides the segmentation of the Primary Sclerosing Cholangitis epidemiology. Report Highlights 11-year Forecast of Primary Sclerosing Cholangitis Epidemiology7MM CoveragePrevalent cases of Primary Sclerosing CholangitisPrevalence of Primary Sclerosing Cholangitis by genderComorbidities associated with Primary Sclerosing Cholangitis KOL ViewsThe publisher interviews KOLs and includes SME's opinion through primary research to fill the data gaps and validate the secondary research. The opinion helps understand the total patient population and current treatment pattern. It will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.Key Questions Answered What will be the growth opportunities in the 7MM concerning the patient population pertaining to Primary Sclerosing Cholangitis?What are the key findings pertaining to the Primary Sclerosing Cholangitis epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?What would be the total number of patients of Primary Sclerosing Cholangitis across the 7MM during the forecast period (2017-2030)?Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?What is the disease risk, burden and unmet needs of Primary Sclerosing Cholangitis?What are the currently available treatments of Primary Sclerosing Cholangitis? The report will allow the user to: Develop business strategies by understanding the trends shaping and driving the global Primary Sclerosing Cholangitis market.Quantify patient populations in the global Primary Sclerosing Cholangitis market to improve product design, pricing, and launch plansOrganize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Primary Sclerosing Cholangitis therapeutics in each of the markets coveredUnderstand the magnitude of Primary Sclerosing Cholangitis population by its epidemiologyThe proprietary Primary Sclerosing Cholangitis Epidemiology model is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources Key Assessments Patient SegmentationDisease Risk and BurdenRisk of disease by the segmentationFactors driving growth in a specific patient population Key Topics Covered 1 Key Insights2 Executive Summary of Primary Sclerosing Cholangitis3 SWOT Analysis for Primary Sclerosing Cholangitis4 Primary Sclerosing Cholangitis Market Overview at a Glance4.1 Market Share (%) Distribution of PSC in 20174.2 Market Share (%) Distribution of PSC in 20305 Disease Background and Overview5.1 Introduction5.2 Etiology5.3 Signs and Symptoms5.4 Risk Factors and genetics5.5 Clinical Phenotypes5.6 Pathophysiology5.6.1 Immunopathology of PSC5.7 Associated Diseases and Complications5.8 Clinical Presentation5.9 Diagnostic Investigations 5.10 Cancer Surveillance in PSC6 Epidemiology and Patient Population6.1 Key Findings6.2 Total Prevalent Population of Primary Sclerosing Cholangitis in 7MM6.3 Assumption and Rationale: 7MM7 Country-wise Epidemiology of Primary Sclerosing Cholangitis7.1 The United States7.1.1 Prevalent cases of Primary Sclerosing Cholangitis in the United States7.1.2 Prevalence of Primary Sclerosing Cholangitis by Gender in the United States7.1.3 Comorbidities associated with Primary Sclerosing Cholangitis in the United States7.2 Germany7.3 France7.4 Italy7.5 Spain7.6 The United Kingdom7.7 Japan8 Treatment and Management8.1 Guidelines8.1.1 American College of Gastroenterology Guidelines8.1.2 AASLD Guidelines for treatment and management of PSC8.1.3 British Society of Gastroenterology and UK-PSC guidelines for the Diagnosis and Management of primary sclerosing cholangitis8.2 Patient Journey8.3 Case study8.3.1 Primary Sclerosing Cholangitis: As case Discussion in the US9 Unmet Needs10 Appendix10.1 Report Methodology For more information about this report visit https://www.researchandmarkets.com/r/39npjs Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Simon Reeve: ‘I’ve been in darkness. I know that for all of us there can be light at the end of a tunnel’

    Simon Reeve is tipped as the new David Attenborough. He tells Katie Strick about post-Covid travel and his mental health journey

  • Growth Opportunities for Marine ingredients in Personal Care

    In the personal care industry, over the last couple of years, the industry trend is moving from clean, green and natural ingredients (green beauty) to blue beauty which not only focuses on checking the ingredients and packaging that can be harmful to oceans, but also harvesting of marine-derived ingredients such as micro-algae and seaweed.New York, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Growth Opportunities for Marine ingredients in Personal Care" - https://www.reportlinker.com/p06010577/?utm_source=GNW These marine ingredients have applications in skin care, hair care, as well as for health and wellness and fitness products. This research report discusses the various marine ingredients for personal care, mainly skin care products. The report focuses on recent technology innovations in marine ingredients. Their benefits, and opportunities in skin care products including moisturizer, anti-aging, antioxidant, skin repair and regeneration, cleanser products. The research also explains the partnerships and acquisitions in this space, intellectual property analysis, companies to action and growth opportunities.Read the full report: https://www.reportlinker.com/p06010577/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • Texas governor's hands-off approach to Covid-19 has allowed the virus to thrive

    Texas governor's hands-off approach to Covid-19 has allowed the virus to thriveHospitals in the state are overwhelmed with more than 13,500 coronavirus patients and a Republican leader rejecting lockdowns

  • Mitch McConnell 'plays the long game' to retain some power as it slips away

    Mitch McConnell 'plays the long game' to retain some power as it slips awayOut of power in the chamber, the Republican now faces unruly politicians and pressure over how to handle Trump impeachment

  • Trump's second impeachment trial: the key players

    Trump's second impeachment trial: the key players67 senators are needed for a guilty verdict and conviction after House charged Trump with ‘incitement of insurrection’

  • Schumer promises quick but fair trial as Trump impeachment heads to Senate

    Schumer promises quick but fair trial as Trump impeachment heads to Senate * Ex-president forms legal team before February hearings * Biden focuses on nominations and legislative priorities * Trump plots revenge on Republicans who betrayed him

  • Someone you loved: how British pop could fade out in Europe

    Someone you loved: how British pop could fade out in Europe. Brexit rule changes that make it tricky to tour the EU will hold back UK artists from a fast-growing market

  • Mother admits killing disabled son in lockdown

    A prosecutor said the manslaughter plea was acceptable to the Crown.

  • Talenom Plc will publish its Financial Statements Bulletin for 2020 on 8 February 2021 at 13:30 EET

    Talenom Plc, Press release 25 January 2021 at 12:00 EETTalenom Plc will publish its Financial Statements Bulletin for 2020 on 8 February 2021 at 13:30 EETTalenom Plc will publish its Financial Statements Bulletin for 2020 on Monday 8 February 2021 at 13:30 EET. The company’s CEO Otto-Pekka Huhtala will present the highlights of the release for analysts, investors and media in Finnish, followed by CFO Antti Aho’s presentation in English as a live webcast on Monday 8 February 2021 at 14:00 EET.The webcast can be viewed online at https://talenom.videosync.fi/tilinpaatos-2020. Participants will have the opportunity to present questions during the briefing over the webcast platform.The presentation materials will be published before the start of the briefing on the company’s website at Talenom.fi/en/investors.TALENOM PLCFurther information: Otto-Pekka Huhtala CEO, Talenom Plc +358 40 703 8554 otto-pekka.huhtala@talenom.fiTalenom is an agile and progressive accounting firm established in 1972. Our business idea is to make day-to-day life easier for entrepreneurs with the easiest-to-use digital tools on the market and highly automated services. In addition to comprehensive accounting services, we support our clients' business with a wide range of expert services as well as financing and banking services. Our vision is to provide unbeatable accounting and banking services for SMEs.DISTRIBUTION: Main media www.talenom.fi

  • STMicroelectronics Announces Status of Common Share Repurchase Program

    PR N°C2980C STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from Jan 18, 2021 to Jan 22, 2021 AMSTERDAM – January 25, 2021 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global semiconductor leader serving customers across the spectrum of electronics applications, announces full details of its common share repurchase program (the “Program”) disclosed via a press release dated November 5, 2018. The Program was approved by a shareholder resolution dated May 31, 2018 and by the supervisory board. STMicroelectronics N.V. (registered with the trade register under number 33194537) (LEI: 213800Z8NOHIKRI42W10) (Ticker: “STM”) announces the repurchase (by a broker acting for the Company) on the regulated market of Euronext Paris, in the period between January 18, 2021 to January 22, 2021 (the “Period”), of 357,723 ordinary shares (equal to 0.04% of its issued share capital) at the weighted average purchase price per share of EUR 33.1553 and for an overall price of EUR 11,860,426.59. Below is a summary of the repurchase transactions made in the course of the Period in relation to the ordinary shares of STM (ISIN: NL0000226223), in detailed form. Transactions in Period Dates of transactionNumber of share purchasedWeighted average purchase price per share (EUR)Total amount paid (EUR)Market on which the shares were bought (MIC code)Jan 18, 2021 73,869 33.0994 2,445,019.58 XPARJan 19, 2021 79,307 32.9757 2,615,203.84 XPARJan 20, 2021 82,241 33.5440 2,758,692.10 XPARJan 21, 2021 60,340 33.5238 2,022,826.09 XPARJan 22, 2021 61,966 32.5773 2,018,684.97 XPARTotal for Period 357,72333.1553 11,860,426.59 Following the share buybacks detailed above, the Company holds in total 6,855,864 treasury shares, which represents approximately 0.8% of the Company’s issued share capital. In accordance with Article 5(1)(b) of Regulation (EU) 596/2014 (the Market Abuse Regulation) and Article 2(3) of Commission Delegated Regulation (EU) 2016/1052, a full breakdown of the individual trades in the Program are disclosed on the ST website (https://investors.st.com/buyback-program). About STMicroelectronicsAt ST, we are 46,000 creators and makers of semiconductor technologies mastering the semiconductor supply chain with state-of-the-art manufacturing facilities. An independent device manufacturer, we work with our 100,000 customers and thousands of partners to design and build products, solutions, and ecosystems that address their challenges and opportunities, and the need to support a more sustainable world. Our technologies enable smarter mobility, more efficient power and energy management, and the wide-scale deployment of the Internet of Things and 5G technology. Further information can be found at www.st.com. For further information, please contact: INVESTOR RELATIONS:Céline BerthierGroup VP, Investor RelationsTel : +41.22.929.58.12celine.berthier@st.com MEDIA RELATIONS:Alexis Breton Corporate External CommunicationsTel: + 33.6.59.16.79.08alexis.breton@st.com Attachment C2980C - ST -- Disclosure of transactions in Own Shares PR -- 25 January 2021 - FINAL FOR PUBLICATION

  • Amadis Appoints Fabrice Grenier as Business Architect, Global Lead

    Amadis Strengthens Global and European Presence with Fabrice Grenier, expert in Business Solutions Architecture

  • dynaCERT Announces Major Carbon Credit Advancements with Verra

    dynaCERT Inc. (TSX: DYA) (OTCQX: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce that the executive management of Verra, which manages the world’s largest greenhouse gas program, the Verified Carbon Standard, has approved the concept note of dynaCERT that is designed to secure Carbon Credits by deploying dynaCERT’s patented HydraGEN™ Technology and HydraLytica™ Telematics on a global basis.